BACKGROUND: The diagnosis and treatment of prostate cancer is a controversial topic.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Until recently there has not been a reliable imaging modality for identification of cancer within the prostate. New evidence suggests that multiparametric magngenetic resonance imaging (MRI) has the potential to improve the diagnosis and treatment of prostate cancer.
OBJECTIVE: This article explains the potential roles for multiparametric MRI in the diagnosis and treatment of prostate cancer.
DISCUSSION: Multiparametric MRI can help identify regions which may represent clinically significant prostate cancer. MRI may also be used to guide varying prostate cancer treatment modalities. An experienced radiologist and adequately powered MRI scanner are essential. Multiparametric MRI in the hands of an experienced uroradiology team is emerging as a useful tool in the diagnosis and treatment of prostate cancer however this technology is still in its infancy and requires further evaluation. At this time prostate MRI should only be ordered by the treating urologist.
Pedler K, Kitzing YX, Varol C, Arianayagam M. Are you the author?
MBBS FRACS (Urol), Urology Fellow, Nepean Hospital, Kingswood, NSW.
Reference: Aust Fam Physician. 2015 Apr;44(4):225-30.